Omaxe Limited Logo

Omaxe Limited

OMAXE.NS

(1.0)
Stock Price

115,94 INR

-2.89% ROA

-57.74% ROE

-4.38x PER

Market Cap.

16.031.232.808,00 INR

150.98% DER

0% Yield

-26.53% NPM

Omaxe Limited Stock Analysis

Omaxe Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Omaxe Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's PBV ratio (1.14x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

2 DER

The stock has a reasonable amount of debt compared to its ownership (84%), suggesting a balanced financial position and a moderate level of risk.

3 Assets Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

4 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

5 ROE

The stock's ROE indicates a negative return (-29.66%) on shareholders' equity, suggesting poor financial performance.

6 ROA

The stock's ROA (-2.94%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

7 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

The company's stock appears overvalued (-253) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Omaxe Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Omaxe Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Buy
4 Stoch RSI Hold

Omaxe Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Omaxe Limited Revenue
Year Revenue Growth
2007 22.816.170.000
2008 7.987.910.000 -185.63%
2009 10.012.230.000 20.22%
2010 15.216.030.000 34.2%
2011 18.487.480.000 17.7%
2012 20.571.230.000 10.13%
2013 16.054.300.000 -28.14%
2014 14.133.430.000 -13.59%
2015 16.535.540.000 14.53%
2016 16.267.530.000 -1.65%
2017 18.390.940.000 11.55%
2018 11.665.100.000 -57.66%
2019 11.214.300.000 -4.02%
2020 4.757.000.000 -135.74%
2021 6.178.000.000 23%
2022 7.733.300.000 20.11%
2023 10.643.600.000 27.34%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Omaxe Limited Research and Development Expenses
Year Research and Development Expenses Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Omaxe Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2007 346.560.000
2008 364.260.000 4.86%
2009 232.910.000 -56.4%
2010 320.360.000 27.3%
2011 438.220.000 26.9%
2012 240.090.000 -82.52%
2013 519.370.000 53.77%
2014 275.640.000 -88.42%
2015 216.660.000 -27.22%
2016 424.410.000 48.95%
2017 279.460.000 -51.87%
2018 0 0%
2019 234.700.000 100%
2020 169.100.000 -38.79%
2021 180.500.000 6.32%
2022 393.600.000 54.14%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Omaxe Limited EBITDA
Year EBITDA Growth
2007 6.810.120.000
2008 1.655.360.000 -311.4%
2009 2.116.140.000 21.77%
2010 2.403.080.000 11.94%
2011 2.616.240.000 8.15%
2012 2.429.310.000 -7.69%
2013 2.474.590.000 1.83%
2014 2.563.340.000 3.46%
2015 2.645.700.000 3.11%
2016 2.970.740.000 10.94%
2017 3.023.530.000 1.75%
2018 1.610.700.000 -87.72%
2019 2.341.100.000 31.2%
2020 -971.600.000 340.95%
2021 -464.600.000 -109.13%
2022 -2.758.400.000 83.16%
2023 -2.531.600.000 -8.96%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Omaxe Limited Gross Profit
Year Gross Profit Growth
2007 22.816.170.000
2008 7.987.910.000 -185.63%
2009 10.012.230.000 20.22%
2010 15.216.030.000 34.2%
2011 3.497.190.000 -335.09%
2012 4.314.040.000 18.93%
2013 4.202.470.000 -2.65%
2014 3.811.310.000 -10.26%
2015 4.181.200.000 8.85%
2016 4.422.630.000 5.46%
2017 4.265.000.000 -3.7%
2018 2.887.000.000 -47.73%
2019 3.356.100.000 13.98%
2020 21.900.000 -15224.66%
2021 601.700.000 96.36%
2022 -929.600.000 164.73%
2023 -1.180.800.000 21.27%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Omaxe Limited Net Profit
Year Net Profit Growth
2007 4.948.760.000
2008 413.140.000 -1097.84%
2009 1.125.540.000 63.29%
2010 927.120.000 -21.4%
2011 903.970.000 -2.56%
2012 1.056.790.000 14.46%
2013 785.200.000 -34.59%
2014 600.680.000 -30.72%
2015 783.220.000 23.31%
2016 1.020.880.000 23.28%
2017 839.980.000 -21.54%
2018 490.100.000 -71.39%
2019 -972.200.000 150.41%
2020 -2.351.800.000 58.66%
2021 -1.595.300.000 -47.42%
2022 -3.479.100.000 54.15%
2023 -3.374.000.000 -3.11%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Omaxe Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2007 24
2008 2 -1050%
2009 5 60%
2010 4 -25%
2011 4 0%
2012 6 20%
2013 4 -25%
2014 3 -33.33%
2015 4 25%
2016 6 20%
2017 5 -25%
2018 3 -100%
2019 -5 140%
2020 -13 58.33%
2021 -9 -50%
2022 -19 57.89%
2023 -18 -5.56%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Omaxe Limited Free Cashflow
Year Free Cashflow Growth
2007 -8.566.150.000
2008 2.177.710.000 493.36%
2009 5.328.730.000 59.13%
2010 5.771.220.000 7.67%
2011 5.502.390.000 -4.89%
2012 4.386.460.000 -25.44%
2013 1.205.960.000 -263.73%
2014 3.518.600.000 65.73%
2015 2.337.900.000 -50.5%
2016 1.010.200.000 -131.43%
2017 33.210.000 -2941.85%
2018 3.855.600.000 99.14%
2019 7.080.900.000 45.55%
2020 5.585.000.000 -26.78%
2021 7.659.400.000 27.08%
2022 4.485.600.000 -70.76%
2023 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Omaxe Limited Operating Cashflow
Year Operating Cashflow Growth
2007 -8.139.340.000
2008 2.269.540.000 458.63%
2009 5.407.150.000 58.03%
2010 6.024.610.000 10.25%
2011 5.736.930.000 -5.01%
2012 4.863.920.000 -17.95%
2013 1.389.450.000 -250.06%
2014 3.619.540.000 61.61%
2015 2.495.140.000 -45.06%
2016 1.208.540.000 -106.46%
2017 190.720.000 -533.67%
2018 4.004.900.000 95.24%
2019 7.178.300.000 44.21%
2020 5.659.500.000 -26.84%
2021 7.830.900.000 27.73%
2022 4.690.000.000 -66.97%
2023 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Omaxe Limited Capital Expenditure
Year Capital Expenditure Growth
2007 426.810.000
2008 91.830.000 -364.78%
2009 78.420.000 -17.1%
2010 253.390.000 69.05%
2011 234.540.000 -8.04%
2012 477.460.000 50.88%
2013 183.490.000 -160.21%
2014 100.940.000 -81.78%
2015 157.240.000 35.81%
2016 198.340.000 20.72%
2017 157.510.000 -25.92%
2018 149.300.000 -5.5%
2019 97.400.000 -53.29%
2020 74.500.000 -30.74%
2021 171.500.000 56.56%
2022 204.400.000 16.1%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Omaxe Limited Equity
Year Equity Growth
2007 14.140.100.000
2008 14.778.240.000 4.32%
2009 15.818.370.000 6.58%
2010 16.777.610.000 5.72%
2011 17.704.500.000 5.24%
2012 18.586.030.000 4.74%
2013 21.786.260.000 14.69%
2014 22.265.520.000 2.15%
2015 22.903.230.000 2.78%
2016 21.186.240.000 -8.1%
2017 21.968.520.000 3.56%
2018 17.561.100.000 -25.1%
2019 16.558.800.000 -6.05%
2020 14.218.900.000 -16.46%
2021 12.599.100.000 -12.86%
2022 9.100.100.000 -38.45%
2023 7.192.500.000 -26.52%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Omaxe Limited Assets
Year Assets Growth
2007 42.806.730.000
2008 41.863.040.000 -2.25%
2009 43.160.440.000 3.01%
2010 45.605.640.000 5.36%
2011 54.139.320.000 15.76%
2012 56.738.410.000 4.58%
2013 64.530.080.000 12.07%
2014 69.079.100.000 6.59%
2015 72.992.820.000 5.36%
2016 83.259.080.000 12.33%
2017 81.279.780.000 -2.44%
2018 107.601.400.000 24.46%
2019 105.491.200.000 -2%
2020 110.423.400.000 4.47%
2021 119.181.200.000 7.35%
2022 135.602.400.000 12.11%
2023 139.401.800.000 2.73%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Omaxe Limited Liabilities
Year Liabilities Growth
2007 28.659.490.000
2008 27.082.520.000 -5.82%
2009 27.339.670.000 0.94%
2010 28.826.140.000 5.16%
2011 36.432.800.000 20.88%
2012 38.149.850.000 4.5%
2013 42.740.540.000 10.74%
2014 46.719.480.000 8.52%
2015 49.996.370.000 6.55%
2016 61.923.750.000 19.26%
2017 59.150.630.000 -4.69%
2018 90.040.300.000 34.31%
2019 88.932.400.000 -1.25%
2020 96.204.500.000 7.56%
2021 106.582.100.000 9.74%
2022 126.502.300.000 15.75%
2023 132.209.300.000 4.32%

Omaxe Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
55.36
Net Income per Share
-21.98
Price to Earning Ratio
-4.38x
Price To Sales Ratio
1.58x
POCF Ratio
0
PFCF Ratio
0
Price to Book Ratio
2.49
EV to Sales
2.35
EV Over EBITDA
-6.98
EV to Operating CashFlow
0
EV to FreeCashFlow
0
Earnings Yield
-0.23
FreeCashFlow Yield
0
Market Cap
16,03 Bil.
Enterprise Value
23,83 Bil.
Graham Number
138.22
Graham NetNet
-371.45

Income Statement Metrics

Net Income per Share
-21.98
Income Quality
0
ROE
-1
Return On Assets
0
Return On Capital Employed
0
Net Income per EBT
0.79
EBT Per Ebit
1.32
Ebit per Revenue
-0.25
Effective Tax Rate
0.2

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
-0.1
Operating Profit Margin
-0.25
Pretax Profit Margin
-0.34
Net Profit Margin
-0.27

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
-0.17
Return on Tangible Assets
-0.03
Days Sales Outstanding
141.57
Days Payables Outstanding
346.73
Days of Inventory on Hand
3327.25
Receivables Turnover
2.58
Payables Turnover
1.05
Inventory Turnover
0.11
Capex per Share
0

Balance Sheet

Cash per Share
42,71
Book Value per Share
38,63
Tangible Book Value per Share
36.89
Shareholders Equity per Share
38.63
Interest Debt per Share
64.49
Debt to Equity
1.51
Debt to Assets
0.08
Net Debt to EBITDA
-2.28
Current Ratio
1.01
Tangible Asset Value
6,75 Bil.
Net Current Asset Value
-5,46 Bil.
Invested Capital
1.51
Working Capital
0,81 Bil.
Intangibles to Total Assets
0
Average Receivables
1,96 Bil.
Average Payables
5,57 Bil.
Average Inventory
53484450000
Debt to Market Cap
0.67

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Omaxe Limited Dividends
Year Dividends Growth
2008 3
2013 1 0%
2014 1 0%
2015 1 0%
2016 1 0%
2017 1 0%
2018 1 0%
2019 1 0%

Omaxe Limited Profile

About Omaxe Limited

Omaxe Limited engages in the real estate development activities in India. It develops and sells integrated and hi-tech townships, group housing projects, shopping malls, office spaces, SCOs, and hotels. The company was formerly known as Omaxe Construction Limited and changed its name to Omaxe Limited in June 2006. Omaxe Limited was founded in 1987 and is based in New Delhi, India. Omaxe Limited is a subsidiary of Guild Builders Private Limited.

CEO
Mr. Rohtas Goel
Employee
473
Address
Omaxe House
New Delhi, 110019

Omaxe Limited Executives & BODs

Omaxe Limited Executives & BODs
# Name Age
1 Ms. Vijayalaxmi Purohit
President
70
2 Mr. Bhupendra Singh
President
70
3 Mr. Abhinav Chand Ajmera
President of Leasing
70
4 Mr. Ram Saran Nigam
President
70
5 Mr. Atul Banshal
Director of Finance
70
6 Mr. Manoj Kumar Dua
Chief Financial Officer
70
7 Mr. Jatin Goel
Director of Operations & Executive Director
70
8 Mr. Vinit Goyal
Whole Time Director
70
9 Mr. Rohtas Goel
Founder & Non-Executive Chairman
70
10 Mr. Mohit Goel
MD & Director
70

Omaxe Limited Competitors

Parsvnath Developers Limited Logo
Parsvnath Developers Limited

PARSVNATH.NS

(1.8)
Sobha Limited Logo
Sobha Limited

SOBHA.NS

(1.2)
Puravankara Limited Logo
Puravankara Limited

PURVA.NS

(1.2)
Brigade Enterprises Limited Logo
Brigade Enterprises Limited

BRIGADE.NS

(3.0)
Indiabulls Real Estate Limited Logo
Indiabulls Real Estate Limited

IBREALEST.NS

(1.2)